RNA Interference Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Surgery Type (Nanoparticle Drug Delivery Technology, Pulmonary Drug Delivery Technology, Nucleic Acid Drug Delivery Technology, Aptamer Drug Delivery Technology); Application (Infectious Diseases, Cardiology, Oncology, Neurology, Ophthalmology, Metabolic Disorders)

Report Code: TIPRE00021846 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

RNA interference (RNAi) is an important technique for studying gene functions in eukaryotes. It is also important for the development of therapeutic gene silencing. The ability of a cell to suppress the expression of a specific gene is referred to as "gene silencing."

MARKET DYNAMICS

Several factors are driving the global RNAi drug delivery market, including increased RNA therapeutics studies, an increase in the number of academic research institutes, and an increase in the prevalence of chronic diseases such as cardiac defects and cancer. High testing costs, however, and the possibility of failure, will stifle business growth. Expansion of science in the field of nanotechnology will provide opportunities for advancement.

MARKET SCOPE

The "RNA Interference Drug Delivery Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of RNA Interference Drug Delivery Market with detailed market segmentation by type, application. The RNA Interference Drug Delivery Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in RNA Interference Drug Delivery Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The RNA Interference Drug Delivery Market is segmented on the basis of type, application. Based on surgery type, the market is segmented as Nanoparticle Drug Delivery Technology, Pulmonary Drug Delivery Technology, Nucleic Acid Drug Delivery Technology, Aptamer Drug Delivery Technology. Based on application, the market is segmented Infectious Diseases, Cardiology, Oncology, Neurology, Ophthalmology, Metabolic Disorders.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the RNA Interference Drug Delivery Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The RNA Interference Drug Delivery Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting RNA Interference Drug Delivery Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the RNA Interference Drug Delivery Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the RNA Interference Drug Delivery Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from RNA Interference Drug Delivery Market are anticipated to have lucrative growth opportunities in the future with the rising demand for RNA Interference Drug Delivery Market in the global market. Below mentioned is the list of few companies engaged in the RNA Interference Drug Delivery Market.

The report also includes the profiles of key players in RNA Interference Drug Delivery Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck
  •   Isis Pharmaceuticals, Inc
  •   Access Pharmaceuticals Inc.
  •   Dicerna Pharmaceuticals Inc.
  •   Calondo Pharmaceuticals Inc.
  •   Marina Biotech Inc.
  •   RXi Pharmaceuticals Corp.
  •   Quark Pharmaceuticals Inc.
  •   Silence Therapeutics plc
  •   Tacere Therapeutics Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 RNA Interference Drug Delivery Market - By Type
1.3.2 RNA Interference Drug Delivery Market - By Application
1.3.3 RNA Interference Drug Delivery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RNA INTERFERENCE DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RNA INTERFERENCE DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RNA INTERFERENCE DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. RNA INTERFERENCE DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. RNA INTERFERENCE DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RNA INTERFERENCE DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NANOPARTICLE DRUG DELIVERY TECHNOLOGY
7.3.1. Overview
7.3.2. Nanoparticle Drug Delivery Technology Market Forecast and Analysis
7.4. PULMONARY DRUG DELIVERY TECHNOLOGY
7.4.1. Overview
7.4.2. Pulmonary Drug Delivery Technology Market Forecast and Analysis
7.5. NUCLEIC ACID DRUG DELIVERY TECHNOLOGY
7.5.1. Overview
7.5.2. Nucleic Acid Drug Delivery Technology Market Forecast and Analysis
7.6. APTAMER DRUG DELIVERY TECHNOLOGY
7.6.1. Overview
7.6.2. Aptamer Drug Delivery Technology Market Forecast and Analysis
8. RNA INTERFERENCE DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. INFECTIOUS DISEASES
8.3.1. Overview
8.3.2. Infectious Diseases Market Forecast and Analysis
8.4. CARDIOLOGY
8.4.1. Overview
8.4.2. Cardiology Market Forecast and Analysis
8.5. ONCOLOGY
8.5.1. Overview
8.5.2. Oncology Market Forecast and Analysis
8.6. NEUROLOGY
8.6.1. Overview
8.6.2. Neurology Market Forecast and Analysis
8.7. OPHTHALMOLOGY
8.7.1. Overview
8.7.2. Ophthalmology Market Forecast and Analysis
8.8. METABOLIC DISORDERS
8.8.1. Overview
8.8.2. Metabolic Disorders Market Forecast and Analysis
9. RNA INTERFERENCE DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America RNA Interference Drug Delivery Market Overview
9.1.2 North America RNA Interference Drug Delivery Market Forecasts and Analysis
9.1.3 North America RNA Interference Drug Delivery Market Forecasts and Analysis - By Type
9.1.4 North America RNA Interference Drug Delivery Market Forecasts and Analysis - By Application
9.1.5 North America RNA Interference Drug Delivery Market Forecasts and Analysis - By Countries
9.1.5.1 United States RNA Interference Drug Delivery Market
9.1.5.1.1 United States RNA Interference Drug Delivery Market by Type
9.1.5.1.2 United States RNA Interference Drug Delivery Market by Application
9.1.5.2 Canada RNA Interference Drug Delivery Market
9.1.5.2.1 Canada RNA Interference Drug Delivery Market by Type
9.1.5.2.2 Canada RNA Interference Drug Delivery Market by Application
9.1.5.3 Mexico RNA Interference Drug Delivery Market
9.1.5.3.1 Mexico RNA Interference Drug Delivery Market by Type
9.1.5.3.2 Mexico RNA Interference Drug Delivery Market by Application
9.2. EUROPE
9.2.1 Europe RNA Interference Drug Delivery Market Overview
9.2.2 Europe RNA Interference Drug Delivery Market Forecasts and Analysis
9.2.3 Europe RNA Interference Drug Delivery Market Forecasts and Analysis - By Type
9.2.4 Europe RNA Interference Drug Delivery Market Forecasts and Analysis - By Application
9.2.5 Europe RNA Interference Drug Delivery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany RNA Interference Drug Delivery Market
9.2.5.1.1 Germany RNA Interference Drug Delivery Market by Type
9.2.5.1.2 Germany RNA Interference Drug Delivery Market by Application
9.2.5.2 France RNA Interference Drug Delivery Market
9.2.5.2.1 France RNA Interference Drug Delivery Market by Type
9.2.5.2.2 France RNA Interference Drug Delivery Market by Application
9.2.5.3 Italy RNA Interference Drug Delivery Market
9.2.5.3.1 Italy RNA Interference Drug Delivery Market by Type
9.2.5.3.2 Italy RNA Interference Drug Delivery Market by Application
9.2.5.4 Spain RNA Interference Drug Delivery Market
9.2.5.4.1 Spain RNA Interference Drug Delivery Market by Type
9.2.5.4.2 Spain RNA Interference Drug Delivery Market by Application
9.2.5.5 United Kingdom RNA Interference Drug Delivery Market
9.2.5.5.1 United Kingdom RNA Interference Drug Delivery Market by Type
9.2.5.5.2 United Kingdom RNA Interference Drug Delivery Market by Application
9.2.5.6 Rest of Europe RNA Interference Drug Delivery Market
9.2.5.6.1 Rest of Europe RNA Interference Drug Delivery Market by Type
9.2.5.6.2 Rest of Europe RNA Interference Drug Delivery Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific RNA Interference Drug Delivery Market Overview
9.3.2 Asia-Pacific RNA Interference Drug Delivery Market Forecasts and Analysis
9.3.3 Asia-Pacific RNA Interference Drug Delivery Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific RNA Interference Drug Delivery Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific RNA Interference Drug Delivery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia RNA Interference Drug Delivery Market
9.3.5.1.1 Australia RNA Interference Drug Delivery Market by Type
9.3.5.1.2 Australia RNA Interference Drug Delivery Market by Application
9.3.5.2 China RNA Interference Drug Delivery Market
9.3.5.2.1 China RNA Interference Drug Delivery Market by Type
9.3.5.2.2 China RNA Interference Drug Delivery Market by Application
9.3.5.3 India RNA Interference Drug Delivery Market
9.3.5.3.1 India RNA Interference Drug Delivery Market by Type
9.3.5.3.2 India RNA Interference Drug Delivery Market by Application
9.3.5.4 Japan RNA Interference Drug Delivery Market
9.3.5.4.1 Japan RNA Interference Drug Delivery Market by Type
9.3.5.4.2 Japan RNA Interference Drug Delivery Market by Application
9.3.5.5 South Korea RNA Interference Drug Delivery Market
9.3.5.5.1 South Korea RNA Interference Drug Delivery Market by Type
9.3.5.5.2 South Korea RNA Interference Drug Delivery Market by Application
9.3.5.6 Rest of Asia-Pacific RNA Interference Drug Delivery Market
9.3.5.6.1 Rest of Asia-Pacific RNA Interference Drug Delivery Market by Type
9.3.5.6.2 Rest of Asia-Pacific RNA Interference Drug Delivery Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa RNA Interference Drug Delivery Market Overview
9.4.2 Middle East and Africa RNA Interference Drug Delivery Market Forecasts and Analysis
9.4.3 Middle East and Africa RNA Interference Drug Delivery Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa RNA Interference Drug Delivery Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa RNA Interference Drug Delivery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa RNA Interference Drug Delivery Market
9.4.5.1.1 South Africa RNA Interference Drug Delivery Market by Type
9.4.5.1.2 South Africa RNA Interference Drug Delivery Market by Application
9.4.5.2 Saudi Arabia RNA Interference Drug Delivery Market
9.4.5.2.1 Saudi Arabia RNA Interference Drug Delivery Market by Type
9.4.5.2.2 Saudi Arabia RNA Interference Drug Delivery Market by Application
9.4.5.3 U.A.E RNA Interference Drug Delivery Market
9.4.5.3.1 U.A.E RNA Interference Drug Delivery Market by Type
9.4.5.3.2 U.A.E RNA Interference Drug Delivery Market by Application
9.4.5.4 Rest of Middle East and Africa RNA Interference Drug Delivery Market
9.4.5.4.1 Rest of Middle East and Africa RNA Interference Drug Delivery Market by Type
9.4.5.4.2 Rest of Middle East and Africa RNA Interference Drug Delivery Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America RNA Interference Drug Delivery Market Overview
9.5.2 South and Central America RNA Interference Drug Delivery Market Forecasts and Analysis
9.5.3 South and Central America RNA Interference Drug Delivery Market Forecasts and Analysis - By Type
9.5.4 South and Central America RNA Interference Drug Delivery Market Forecasts and Analysis - By Application
9.5.5 South and Central America RNA Interference Drug Delivery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil RNA Interference Drug Delivery Market
9.5.5.1.1 Brazil RNA Interference Drug Delivery Market by Type
9.5.5.1.2 Brazil RNA Interference Drug Delivery Market by Application
9.5.5.2 Argentina RNA Interference Drug Delivery Market
9.5.5.2.1 Argentina RNA Interference Drug Delivery Market by Type
9.5.5.2.2 Argentina RNA Interference Drug Delivery Market by Application
9.5.5.3 Rest of South and Central America RNA Interference Drug Delivery Market
9.5.5.3.1 Rest of South and Central America RNA Interference Drug Delivery Market by Type
9.5.5.3.2 Rest of South and Central America RNA Interference Drug Delivery Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RNA INTERFERENCE DRUG DELIVERY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RNA INTERFERENCE DRUG DELIVERY MARKET, KEY COMPANY PROFILES
12.1. MERCK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ISIS PHARMACEUTICALS, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ACCESS PHARMACEUTICALS INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DICERNA PHARMACEUTICALS INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CALONDO PHARMACEUTICALS INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MARINA BIOTECH INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RXI PHARMACEUTICALS CORP.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QUARK PHARMACEUTICALS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SILENCE THERAPEUTICS PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TACERE THERAPEUTICS INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Tekmira Pharmaceuticals Corp.
2. Alnylam Pharmaceuticals Inc.
3. Merck
4. Isis Pharmaceuticals, Inc
5. Access Pharmaceuticals Inc.
6. Dicerna Pharmaceuticals Inc.
7. Calondo Pharmaceuticals Inc.
8. Marina Biotech Inc.
9. RXi Pharmaceuticals Corp.
10. Quark Pharmaceuticals Inc.
11. Silence Therapeutics plc
12. Tacere Therapeutics Inc.
13. PhaseRx Inc.
14. Sirnaomics Inc.
15. Traversa Therapeutics Inc.
TIPRE00021846
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking